Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
287.70
+1.21 (0.42%)
At close: Jan 16, 2026, 4:00 PM EST
289.00
+1.30 (0.45%)
After-hours: Jan 16, 2026, 5:31 PM EST
Insulet Employees
Insulet had 3,900 employees as of December 31, 2024. The number of employees increased by 900 or 30.00% compared to the previous year.
Employees
3,900
Change (1Y)
900
Growth (1Y)
30.00%
Revenue / Employee
$646,615
Profits / Employee
$63,128
Market Cap
20.24B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3,900 | 900 | 30.00% |
| Dec 31, 2023 | 3,000 | 400 | 15.38% |
| Dec 31, 2022 | 2,600 | 300 | 13.04% |
| Dec 31, 2021 | 2,300 | 400 | 21.05% |
| Dec 31, 2020 | 1,900 | 550 | 40.74% |
| Dec 31, 2019 | 1,350 | 181 | 15.48% |
| Dec 31, 2018 | 1,169 | 312 | 36.41% |
| Dec 31, 2017 | 857 | 217 | 33.91% |
| Dec 31, 2016 | 640 | -7 | -1.08% |
| Dec 31, 2015 | 647 | 128 | 24.66% |
| Dec 31, 2014 | 519 | 41 | 8.58% |
| Dec 31, 2013 | 478 | -60 | -11.15% |
| Dec 31, 2012 | 538 | -38 | -6.60% |
| Dec 31, 2011 | 576 | 266 | 85.81% |
| Dec 31, 2010 | 310 | 34 | 12.32% |
| Dec 31, 2009 | 276 | -18 | -6.12% |
| Dec 31, 2008 | 294 | 47 | 19.03% |
| Dec 31, 2007 | 247 | -47 | -15.99% |
| Dec 31, 2006 | 294 | 47 | 19.03% |
| Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PODD News
- 4 days ago - Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 8 days ago - Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 - Business Wire
- 11 days ago - Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health - Business Wire
- 4 weeks ago - Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 weeks ago - Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future - Business Wire
- 5 weeks ago - Eight stock picks to play one of the healthiest corners of the market - Market Watch
- 6 weeks ago - Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Business Wire
- 7 weeks ago - Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off - Seeking Alpha